Key Insights The projected fair value for Becton Dickinson is US$330 based on 2 Stage Free Cash Flow to Equity ...

Becton, Dickinson and Company BDX, popularly known as BD, recently launched the new BD Intraosseous (IO) Vascular Access ...

Morgan Stanley analyst Patrick Wood maintained a Buy rating on Becton Dickinson (BDX – Research Report) today and set a price target of ...

Investors looking for stocks in the Medical - Dental Supplies sector might want to consider either Becton Dickinson (BDX) or Merit Medical (MMSI). But which of these two stocks offers value investors ...

BD (NYSE:BDX) shares ticked up before hours today on fourth-quarter results that came in ahead of the consensus forecast.

In the last reported quarter, the company’s earnings per share (EPS) of $3.50 surpassed the Zacks Consensus Estimate by 5.7%.

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Stifel Nicolaus analyst Rick Wise maintained a Buy rating on Becton Dickinson (BDX – Research Report) today and set a price target of $280.00. The company’s shares opened today at $226.95. Wise covers ...

Below is Validea's guru fundamental report for BECTON DICKINSON AND CO (BDX). Of the 22 guru strategies we follow, BDX rates highest using our Growth Investor model based on the published strategy ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...